Pfizer

Visual Financials
Company Name: Pfizer Inc
Ticker Symbol: PFE
CIK Number: 0000078003
WWW Address: http://www.pfizer.com
CEO: Albert Bourla
No. of Employees: 96,500
Common Issue Type: CS
Business Description:Pfizer Inc is a research-based biopharmaceutical company. The Company has five operating segments—Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health; and Consumer Healthcare.

 
Industry Information: DRUGS - Drug Manufacturers - Major [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 42.88 Up 0.12 - - 42.7 43.09 42.46 13372836
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 238,409.8 5,559.9 0.00 1.90 1.44 22.1 3.3 46.47 - 35.73
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close42.71$
PE Ratio - LTM22.1
Market Capitalisation238,409.8mil
Latest Shares Outstanding5,559.9mil
Earnings pS (EPS)1.90$
Dividend pS (DPS)1.44¢
Dividend Yield3.3%
Dividend Payout Ratio1%
Revenue per Employee580,595$
Effective Tax Rate0.1%
Float5,549.8mil
Float as % of Shares Outstanding1.0%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue0.10%
Gross Profit Margin79.0%
EBITDA Margin36.5%
Pre-Tax Profit Margin0.0%
Assets Turnover32.4%
Return on Assets (ROA)6.7%
Return on Equity (ROE)16.6%
Return on Capital Invested (ROCI)11.0%
Current Ratio1.6
Leverage Ratio (Assets/Equity)2.5
Interest Cover10.0
Total Debt/Equity (Gearing Ratio)0.66
LT Debt/Total Capital34.0%
Working Capital pS3.25$
Cash pS0.00$
Book-Value pS10.57$
Tangible Book-Value pS-4.54$
Cash Flow pS2.63$
Free Cash Flow pS2.23$
KEY FIGURES (LTM): Price info
Price/Book Ratio3.97
Price/Tangible Book Ratio0.00
Price/Cash Flow15.9
Price/Free Cash Flow18.8
P/E as % of Industry Group52.0%
P/E as % of Sector Segment75.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of PaymentCash Payment
Dividend Rate1.44
Current Dividend Yield3.3
5-Y Average Dividend Yield4.4
Payout Ratio1.0
5-Y Average Payout Ratio70.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---3.123,029,35681,574,998
4 Weeks43.0939.8740.724.924,031,342456,595,508
13 Weeks43.2838.4241.492.923,528,0771,505,796,965
26 Weeks44.9438.1043.92-2.823,952,7112,970,136,180
52 Weeks46.4735.7336.6716.520,941,4415,235,360,421
YTD43.7938.10--1.223,972,4682,589,026,638
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
42.1842.0541.4242.2942.570.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.010.10.03
Income-0.130.00.17
Dividend0.070.20.07
Capital Spending-0.02NA0.03
R&D0.67NA-2.12
Normalized Inc.2.36NA6.12
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-12.4-12.4-12.5
Earnings %53.453.445.2
EPS %58.358.351.6
EPS $0.140.140.66
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio11.33
Current Ratio1.6
Quick Ratio (Acid Test)0.9
Liquidity Ratio (Cash)0.63
Receivables Turnover6.6
Average Collection Period55
Working Capital/Equity28.5
Working Capital pS3.25
Cash-Flow pS2.65
Free Cash-Flow pS2.28
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.88
Financial Leverage Ratio (Assets/Equity)0.7
Debt Ratio26.2
Total Debt/Equity (Gearing Ratio)0.66
LT Debt/Equity0.52
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities78.8
Interest Cover10.0
Interest/Capital Invested2.08
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.46
Current P/E Ratio - LTM22.10
Enterprise Value (EV)/EBITDA10.89
Enterprise Value (EV)/Free Cash Flow19.58
Dividend Yield3.3
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM3.97
Price/Cash Flow Ratio15.9
Price/Free Cash Flow Ratio - LTM18.8
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM14.1
P/E Ratio (26 weeks ago) - LTM19.5
P/E Ratio (52 weeks ago) - LTM18.1
5-Y High P/E Ratio23.8
5-Y Low P/E Ratio14.1
5-Y Average P/E Ratio15.3
Current P/E Ratio as % of 5-Y Average P/E13
P/E as % of Industry Group52.0
P/E as % of Sector Segment75.0
Current 12 Month Normalized P/E Ratio - LTM14.6
PER SHARE FIGURES
LT Debt pS5.53
Current Liabilities pS5.36
Tangible Book Value pS - LTM-4.54
Book Value pS - LTM10.57
Capital Invested pS18.91
Cash pS - LTM0.00
Cash Flow pS - LTM2.63
Free Cash Flow pS - LTM2.23
Earnings pS (EPS)1.90
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin25.41
Free Cash Flow Margin 5YEAR AVG27.27
Net Profit Margin0.3
Net Profit Margin - 5YEAR AVRG.0.2
Equity Productivity0.85
Return on Equity (ROE)0.2
Return on Equity (ROE) - 5YEAR AVRG.0.2
Capital Invested Productivity0.51
Return on Capital Invested (ROCI)0.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.1
Assets Productivity0.30
Return on Assets (ROA)0.1
Return on Assets (ROA) - 5YEAR AVRG.0.1
Gross Profit Margin79.0
Gross Profit Margin - 5YEAR AVRG.0.8
EBITDA Margin - LTM36.5
EBIT Margin - LTM24.6
Pre-Tax Profit Margin0.2
Pre-Tax Profit Margin - 5YEAR AVRG.0.2
Effective Tax Rate10.6
Effective Tax Rate - 5YEAR AVRG.5.7
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee580,595
Net Income per Employee120,703
Average Collection Period
Receivables Turnover6.6
Day's Inventory Turnover Ratio
Inventory Turnover1.5
Inventory/Sales14.0
Accounts Payble/Sales8.71
Assets/Revenue3.33
Net Working Capital Turnover2.97
Fixed Assets Turnover0.49
Total Assets Turnover0.3
Revenue per $ Cash47.10
Revenue per $ Plant4.01
Revenue per $ Common Equity0.85
Revenue per $ Capital Invested0.51
Selling, General & Adm/tive (SG&A) as % of Revenue26.9
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue14.9
R&D Expense as % of Revenue - 5YEAR AVRG.14.9

  
Your Recent History
NYSE
PFE
Pfizer
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20190618 06:46:49